A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Completed

Plain-English translation of NCT00774345 on ClinicalTrials.gov ↗ · Source last updated December 2021 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(241 sites)

United States

Mayo Clinic - Arizona, Phoenix, Arizona

Pacific Coast Hematology Oncology, Fountain Valley, California

Kaiser Permanente Medical Group, San Diego, California

Sharp Memorial Hospital, San Diego, California

Stanford University Stanford, Stanford, California